Disposable Bioreactors Based on Wave Agitation Technology - Disposable bioreactors save costs in time and capital by reducing the time-to-market needed for cell cultivation processes. - BioPharm

ADVERTISEMENT

Disposable Bioreactors Based on Wave Agitation Technology
Disposable bioreactors save costs in time and capital by reducing the time-to-market needed for cell cultivation processes.


BioPharm International


DIANA MARJANOVIC is a product manager of disposable bioreactors at Sartorius AG, Switzerland. Gerhard Greller is a scientist in process development, biotechnology, at Sartorius AG, Germany.

References

1. L. Stryer L. Biochemistry, 4th ed. New York (NY): W.H. Freeman and Company; 1995.

2. Wurm F. Nature Biotech 2004;22: 13–98.

3. Sandig V. et al. Mammalian cells. In: Gelissen G., editor. Production of recombinant proteins. (Wiley-VCH; 2005)

4. Weber W. et al. Catching the Wave: The BEVS and the Biowave. Novartis Pharma Research, Switzerland.

5. Eibl D. and Eibl R. BioWorld 2005; 3:1–2 (Supplement BioteCHnet)

6. Pierce, Bioprocessing J 2004; 3: 51–56.

7. Ling et al., Biotechnol Prog 2003; 19(1), 158–62

8. Weber W. et al. Cytotechn 2002; 38: 77–85.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

J&J Speeds Ebola Vaccine Development and Expands Production
October 24, 2014
Despite AbbVie Snub, Shire Says it Will Double Sales by 2020
October 24, 2014
Manufacturing Challenges of mAb Production: CHO or Plant Cells?
October 24, 2014
Celgene and Sutro Partner on ADC Development
October 24, 2014
GSK Accelerates Ebola Vaccine Development
October 24, 2014
Author Guidelines
Source: BioPharm International,
Click here